中文文獻
1.孔繁鐘譯(2007)。DSM-IV-TR 精神疾病診斷準則手冊。台北:合計出版社。
2.方喬玲、莊淇源、鄒志翔、樓亞洲、陳立奇(2014)。藥師衛教介入改善氣喘控制之成效。北市醫學雜誌,11(3),39-53。3.王署君(2012)。偏頭痛最新診斷與治療。中華民國內膜異位症婦女協會會刊,19(5&6),14 -19。
4.台灣氣喘衛教學會(2008)。過敏性鼻炎診療指引。2017 年5月12日,取自: http://www.asthmaedu.org.tw/asthma/member7.aspx
5.宋桂容(2008)。以Actigraphy評估偏頭痛患者睡眠品質與頭痛之相關性。臺北醫學大學護理學系碩士暨碩士在職專班學位論文。6.李世滄、林宜信、吳玢玢(2007)。失眠中醫典籍彙編。
7.林高章、黃子洲、王博仁、陳滄山、柯炳堂(2012)。偏頭痛的急性及預防性治療準則比較。臺灣醫界,55(12),12 – 18。8.林嘉玲、潘美玉、張媚(2006)。社區老人睡眠品質之探討。台灣醫學,10(4),438-446。
9.林嘉玲、蘇東平、張媚(2003)。機構老人之睡眠品質及其相關因素。台灣醫學,7(2),174-184。
10.林慶雄(2013)。國際性氣喘臨床整合照護計畫評鑑。台灣氣喘衛教學會會刊,29,10-12。
11.林憶杰(2014)。氣喘病患者健康促進生活品質之研究:以天灸療法為例。佛光大學文化資產與創意學系碩士論文。12.邵馨慧、黃麗卿、林啟民、陳采霜(2008)。青少年頭痛與失眠之相關性探討。中華職業醫學雜誌,15(4),291-300。
13.柯佩均(2009)。應用資料探勘技術分析疾病間共現與因果關係-以失眠與心腦血管疾病為例。國立臺灣大學工程科學及海洋工程研究所學位論文。
14.徐世達(2011)。台灣氣喘衛教歷史與現況。台灣氣喘衛教學會會刊,22,11-17。
15.徐炳坤、楊之東、張煥禎(2007)。頭痛的迷思:偏頭痛。基層醫學,22(3),85- 88。16.張羃(2014)。台灣地區睡眠障礙患者之中西醫療服務利用與費用。亞洲大學健康產業管理學系長期照護組研究所學位論文。
17.許永居、林高章、台灣頭痛學會治療準則小組(2017)。偏頭痛急性發作藥物治療準則。2017年6月3日,取自:http://www.taiwanheadache.com.tw/doc/%E6%80%A5%E6%80%A7%E5%81%8F%E9%A0%AD%E7%97%9B%E6%B2%BB%E7%99%82%E6%BA%96%E5%89%87_2017%E4%BF%AE%E8%A8%82.pdf
18.郭震群、呂英豪、陳啟佑、黃耀斌(2012)。疾病診斷與藥物治療一致性之用藥安全調查:以口服降血糖用藥為例。臺灣臨床藥學雜誌,20(1),11 -24。19.陳冠豪(2014)。氣喘患者呼吸道內顆粒沉積之數值模擬。國立成功大學航空太空工程學系碩士論文。20.最新國際頭痛分類第三版中文精簡版。2017年4月20日。取自:http://www.taiwanheadache.com.tw/doc/ICHD3b-tc.pdf
21.游隆權(2001)。過敏性鼻炎的中醫診治。中國中醫臨床醫學雜誌,7(1),123-125。22.黃垣禎(2004)。過敏性鼻炎。傳統醫學雜誌,15,99-100。23.衛生福利部國民健康署 (2013)。國民健康訪問調查。2017年5月22日,取自: http://nhis.nhri.org.tw/2013download.html
24.鄭月雅(2006)。由社會發展趨勢探討國人睡眠品質,2017年5月30日,取自:http://www.dgbas.gov.tw/public/Data/4122719141571.pdf
25.鄭昌賢(2008)。過敏性鼻炎臨床表現與良導絡值之關聯性分析. 國立交通大學理學院碩士在職專班應用科技學程學位論文。26.謝邦昌、謝宛珊(2014)。預防性偏頭痛治療後偏頭痛急性用藥比較之研究。數據分析,9 (6),91-112。
英文文獻
1.Adelman, L.C., Adelman, J.U., Freeman, M.C., Von Seggern, R.L. (2004). Pharmacoeconomics: the cost of prophylactic migraine treatments. Headache,44(10),1050-1055.
2.Aupiais, C., Wanin, S., Romanello, S., Spiri, D., Moretti, R., Boizeau, P., Massano, D., Zuccotti, G.V., Crichiutti, G., Kanagarajah, L., Houdouin, V., Alberti, C., Titomanlio, L. (2017).Association Between Migraine and Atopic Diseases in Childhood: A Potential Protective Role of Anti-Allergic Drugs. Headache, 57(4),612-624.
3.Baroody, F.M., Baroody, Fuad, M. (2003).Allergic rhinitis: broader disease effects and implications for management. Otolaryngology-Head & Neck Surgery, 128(5), 616-631.
4.Bruni, O., GalIi, F., Guidetti, V.(1999). Sleep hygiene and migraine in children and adolescents. Cephalalgia ,19(25),57-59.
5.Calhoun, A.H., Ford, S., Finkel, A.G., Kahn, K.A., Mann, J.D.(2006). The prevalence and spectrum of sleep problems in women with transformed migraine. Headache,46(4),604-610.
6.Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R.(1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases,40(5),373-383.
7.Crans Yoon, Angelina M., Chiu, Vicki, Rana, Jamal S.,Sheikh, Javed.(2016). Association of allergic rhinitis, coronary heart disease, cerebrovascular disease, and all-cause mortality. Annals of Allergy, Asthma & Immunology, 117(4),359-364.
8.Davey, G., Sedgwick, P., Maier, W., Visick, G., Strachan, D.P., Anderson, H.R. (2002). Association between migraine and asthma: matched case-control study. British Journal of General Practice,52(482),723-727.
9.Dirican, N., Demirci, S., Cakir, M. (2017). The relationship between migraine headache and asthma features. Acta Neurologica Belgica, 117(2),531-536.
10.Ferrari, M.D., Klever, R.R., Terwindt, G.M., Ayata, C., van den Maagdenberg, A.M.(2015). Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol ,14,65-80.
11.Fineman, S. M. (2002). The burden of allergic rhinitis: beyond dollars and cents. Annals of allergy, asthma & immunology, 88 (1), 2-7.
12.Ford, D.E., Cooper-Patrick, L.(2001). Sleep disturbances and mood disorders: an epidemiologic perspective. Depress Anxiety, 14(1),3-6.
13.Ford, D.E., Kamerow, D.B.(1989). Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? Journal of the American Medical Association,262(11),1479-84.
14.Groot, V., Beckerman, H., Lankhorst, G.J., Bouter, L.M.(2003). How to measure comorbidity. a critical review of available methods. J Clin Epidemiol, 56(3),221-229.
15.Hershey, A.D.(2010). Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol,9(2):190-204.
16.Iribarren Carlos, Tolstykh Irina, V., Miller Mary, K., Sobel Erica,Eisner Mark, D.(2012). Adult Asthma and Risk of Coronary Heart Disease, Cerebrovascular Disease, and Heart Failure: A Prospective Study of 2 Matched Cohorts. American Journal of Epidemiology, 176(11),1014-1024.
17.Kelman ,L.,Rains, J.C.(2005). Headache and Sleep: Examination of Sleep Patterns and Complaints in a Large Clinical Sample of Migraineurs. Headache, 45(7),904-910.
18.Kelman, L. (2007). The triggers or precipitants of the acute migraine attack. Cephalalgia, 27(5), 394-402.
19.Ku, M., Silverman, B.,Prifti, N., Ying, W., Persaud, Y., Schneider, A.(2006). Prevalence of migraine headaches in patients with allergic rhinitis. Annals of Allergy, Asthma & Immunology, 97(2),226-230.
20.Lay, C.L., Broner, S.W.(2009). Migraine in women. Neurol Clin, 27(2),503-511.
21.Ling-Yu Hsieh, Yi-Hao Peng,Hsiao-Ling Chia.(2016). Migraine is associated with an increased risk of adult-onset asthma: a nationwide cohort study. Respiratory Care , 61(10),55-55.
22.Loder, E.(2010).Triptan therapy in migraine. N Engl J Med ,363(1):63-70.
23.Lugogo, N., Kraft, M. (2006).Epidemiology of asthma. Clin Chest Med, 27(1),1.
24.Magis, D., Schoenen, J.(2011). Treatment of migraine: update on new therapies. Curr Opin Neurol,24(3),203-210.
25.Marcus, D.A.(2006). The migraine-sleep link. Headache & Pain: Diagnostic Challenges, Current Therapy, 17(2),75-78.
26.Marmura, M.J.(2012). Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol,14(1),27-35.
27.Martin Vincent, T., Fanning Kristina, M., Serrano Daniel, Buse Dawn, C., Reed Michael, L., Lipton Richard, B.(2016). Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study. Headache: The Journal of Head & Face Pain, 56(1),118-131.
28.Mollaoglu, M. (2013). Trigger factors in migraine patients. Journal of Health Psychology, 18(7), 984-994.
29.Mueller Noel, T.,Koh Woon-Puay, Odegaard Andrew, O.,Gross Myron, D., Yuan Jian-Min, Pereira Mark, A.(2013). Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study. Diabetes Research & Clinical Practice, 99(2),192-199.
30.Nappi, R.E., Sances, G., Detaddei, S., Ornati, A., Chiovato, L., Polatti, F.(2009). Hormonal management of migraine at menopause. Menopause Int,15(2):82-86.
31.National Center for Health Statistics (2002). Allergies/Hay Fever. National Health Interview Survey2002. Retrieved May 30, 2017, from http://www.cdc.gov/nchs/fastats/allergies.htm
32.Newman, A.B., Enright, P.L., Manolio, T.A., Haponik, E.F., Wahl, P.W.(1997). Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. J Am Geriatr Soc,45(1),1-7.
33.Ozturk, A., Degirmenci, Y., Tokmak, B., Tokmak, A. (2013). Frequency of migraine in patients with allergic rhinitis. Pakistan Journal of Medical Sciences, 29(2),528-531.
34.Pakalnis, A;.,Splaingard, M., Splaingard, D., Kring, D.,Colvin ,A.(2009). Serotonin effects on sleep and emotional disorders in adolescent migraine. Headache,49(10),1486-1492.
35.Peng, Y.H., Chen, K.F., Kao, C.H., Chen, H.J., Hsia, T.C., Chen, C.H., Liao, W.C. (2016). Risk of Migraine in Patients With Asthma: A Nationwide Cohort Study. Medicine (Baltimore), 95(9),e2911.
36.Rosenkranz, M.A., Davidson, R.J.(2009). Affective neural circuitry and mind-body influences in asthma. Neuroimage, 47(3),972-80.
37.Saberi, A., Nemati, S., Shakib, R.J., Kazemnejad, E., Maleki, M.(2012). Association between allergic rhinitis and migraine. Journal of Research in Medical Sciences, 17(6),508-512.
38.Silberstein, S.D.(2000). Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology.55(6),754-762.
39.Smitherman, T.A., Walters, A.B., Davis, R.E., Ambrose, C.E., Roland, M., Houle, T.T., Rains, J.C. (2016). Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia. Headache,56(2),276-291.
40.Starr, C. (1998). Emerging migraine treatments. Patient Care,32(14),78-97.
41.Stovner, L.J., Andree, C., Eurolight Steering, C.(2008). Impact of headache in Europe: a review for the Eurolight project. J Headache Pain ,9(3),139-146.
42.Stovner, L.J., Zwart, J.A., Hagen, K., Terwindt, G.M., Pascual, J.(2006). Epidemiology of headache in Europe. Eur J Neurol,13(4),333-345.
43.UpToDate . Retrieved July 28, 2017, from https://www-uptodate-com.sw.lib.csmu.edu.tw/contents/search?search=&x=11&y=9
44.Wang, I.C., Tsai, J.D., Lin, C.L., Shen, T.C., Li, T.C., Wei, C.C. (2016). Allergic rhinitis and associated risk of migraine among children: a nationwide population-based cohort study. International Forum of Allergy & Rhinology, 6(3),322-327.
45.Wang, S.J., Chung, C.S., Chankrachang, S., Ravishankar, K., Merican, J. S., Salazar, G.,Sakai, F.(2008).Migraine Disability Awareness Campaign in Asia: Migraine Assessment for Prophylaxis. Headache: The Journal of Head and Face Pain, 48(9), 1356-1365.
46.World Health Organization (2003). Fact sheet EURO/01/03: Environmental hazards trigger childhood allergic disorders. Retrieved May 28, 2017, from http://www.euro.who.int/document/mediacentre/fswhde.pdf
47.World Health Organization (2007) .ICD-10International Statistical Classification of Diseases and Related Health Problems(10th Revision, Version for 2007). Retrieved May 29, 2017,from http://www. who.int/classifications/apps/icd/icd10online/
48.Yakupov, E.Z., Aleksandrova, E.A., Troshina, I.V., Shebasheva, E.V., Shagiakhmetova, L.I. (2014). Sleep disorders in the structure of cerebrovascular diseases. Neuroscience and Behavioral Physiology,46(4), 405–407.
49.Zeiger, R.S., Hay, J.W., Contreras, R., Chen, W., Quinn, V.P., Seal, B., Schatz, M.(2008).Asthma costs and utilization in a managed care organization. Journal of Allergy and Clinical Immunology , 121(4),885-892.